TCM
KURA icon

Tang Capital Management’s Kura Oncology KURA Stock Holding History

Tang Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$885K – 140
2025
Q3 		$885K Hold
100,000
– – 0.03% 158
2025
Q2 		$577K Hold
100,000
– – 0.03% 183
2025
Q1 		$660K Hold
100,000
– – 0.04% 178
2024
Q4 		$871K Hold
100,000
– – 0.06% 161
2024
Q3 		$1.95M Hold
100,000
– – 0.14% 99
2024
Q2 		$2.06M Hold
100,000
– – 0.21% 78
2024
Q1 		$2.13M Buy
+100,000
New +$1.94M 0.22% 77

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Tang Capital Management's KURA Position: Q4 2025 in Review

Tang Capital Management sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 100,000 shares — an estimated $885K sold.

Tang Capital Management first reported a position in KURA in Q1 2024 and held it in 7 quarters. The position peaked at $2.13M in Q1 2024. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Tang Capital Management reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 100,000 Kura Oncology shares in Q4 2025, an estimated $885K.
  • Tang Capital Management first reported a position in Kura Oncology in Q1 2024 and held it in 7 quarters.
  • Tang Capital Management's Kura Oncology position peaked at $2.13M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.